Management Team

Management Team

William A. Clark, Ph.D. – Vice President of Science and Strategic Alliances

LinkedIn

Drawing upon his expertise in pharmacology, protein expression and purification, genetic engineering and assay development, Dr. Clark directs PBL’s business development and intellectual property efforts. He also negotiates research, alliance, service, consulting and licensing arrangements with pharmaceutical and biotechnology companies, universities and government laboratories. Dr. Clark earned degrees from Boston College and Yale University, and completed his postdoctoral fellowship at the NIH.

 

Gregory Davies, MBA – Corporate Controller

LinkedIn

Mr. Davies is responsible for managing PBL’s financial functions. He has more than 18 years of financial experience in a variety of industries including supporting an initial public offering and coordinating various debt and equity financing transactions. Mr. Davies received a Bachelor of Science in management from Montclair State University and an MBA in finance from Monmouth University.

 

Thomas B. Lavoie, Ph.D. – Chief Scientific Officer

LinkedIn

Dr. Lavoie oversees all scientific aspects of PBL, providing direction for internal research projects and product development efforts. He is also an essential part of the Business Development team. Prior to PBL, Dr. Lavoie developed assays and proteins for structure based drug discovery at BMS, conducted research at the NIH and received degrees from Frostburg State and UMCP.

 

Alok Pandey, Ph.D. – Director, Assay Services

LinkedIn

Dr. Pandey leads the highly dynamic assay services team responsible for all client-based services, including consultation, assay execution, and data analysis. His team is also heavily involved in custom immunoassay development on cutting-edge platforms such a Simoa, Erenna/SMC, and MSD. Dr. Pandey did his Ph.D. from NBAGR, India, and pursued his postdoctoral research from Rutgers University with a focus on protein biochemistry and assay development.

 

Daniela Rotaru – Director, Manufacturing

LinkedIn

Mrs. Rotaru oversees a team responsible for the manufacturing of ELISA products, interferon proteins, and antibodies, as well as shipping and receiving. She provides strategic direction for the manufacturing department, ensuring production, performance, and quality standards are consistently met; she develops plans for products, processes, and new product transfers with the overarching goal of increasing efficiency and profitability. She received a Bachelor of Economics degree with a focus in Management-Marketing from the University of Craiova Romania. 

 

Mike Skawinski – Chief Operations Officer

LinkedIn

Mr. Skawinski leads a team that produces the proteins for PBL’s products, researches and develops new products, and provides custom assay services for clients. 

 

Vicki Wang – Strategic Initiatives & Operations Manager

LinkedIn

Ms. Wang is responsible for overseeing strategic marketing and communication efforts as well as relationship building with partners around the world. The efforts of her Marketing and Sales team enable our products and services to be discovered and used in research projects worldwide. She obtained her degree from Rutgers University and is currently pursuing an MBA.

 

Karen Zipf, MS – Director, Quality

LinkedIn

Ms. Zipf oversees all quality-related aspects at PBL from products to services. 

 

Find your lot-specific Certificate of Analysis here!

Finding the right biomarker detection service to meet your project needs just got easier...

Sign up for our email list to be kept up-to-date on the latest product releases and company news!

Go to top